300511SZSE

Xuerong Biotechnology Co., Ltd.

雪榕生物

300511

Shenzhen Stock Exchange

Follow
48 announcements tracked· Last: April 27, 2026

Key Financials

Revenue¥678.9M
Net Profit¥173.2M
ROE9.71%
Debt Ratio54.48%
Monetary Funds¥297.5M
Receivables¥46.1M
Total Shares640.8M

Announcements

48 total

Announcement on the Proposed Reappointment of Accounting Firm of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report of Shanghai Xuerong Biotechnology Co., Ltd. (Jiang Dequan)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report of Shanghai Xuerong Biotechnology Co., Ltd. (Li Xueyao - Resigned)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report of Shanghai Xuerong Biotechnology Co., Ltd. (Li Danmeng - Resigned)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report of Shanghai Xuerong Biotechnology Co., Ltd. (Su Dongjun)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report of Shanghai Xuerong Biotechnology Co., Ltd. (Huang Jianchun - Resigned)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report of Shanghai Xuerong Biotechnology Co., Ltd. (Zhang Luxiang)

Convertible BondsShareholding Change DisclosureCapital Reduction

Announcement on the 2025 Online Performance Presentation of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Internal Control Audit Report of Shanghai Xuerong Biotechnology Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Internal Control Self-Assessment Report of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Remuneration Management System for Directors and Senior Management of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Financial Settlement Report of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Work Report of the Board of Directors of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Proposed Reduction of the Scale of Fundraising Investment Projects and Completion of Projects of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Changes in Accounting Policies of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Provision for Inventory Decline in Value for 2025 of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Remuneration Plan for the Lifetime Honorary Chairman for 2026 and Related Transactions of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Expected Guarantee Limit for 2026 of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice of the 2025 Annual Shareholders' Meeting of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Resolution Announcement of the 7th Meeting of the 6th Board of Directors of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Explanation of Shanghai Xuerong Biotechnology Co., Ltd. on the Proposed Non-Distribution of Profits for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Q1 2026 Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Report of the Audit Committee of the Board of Directors of Shanghai Xuerong Biotechnology Co., Ltd. on the Performance Evaluation of the Accounting Firm for 2025 and the Fulfillment of Supervisory Responsibilities

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Explanation on the Fund Occupation Situation of Major Shareholders and Other Related Parties of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for 2025 of Shanghai Xuerong Biotechnology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Opinion of the Board of Directors of Shanghai Xuerong Biotechnology Co., Ltd. on the Independence of Independent Directors

Share Repurchase CompletionConvertible BondsShareholding Change Disclosure

2025 Annual Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Summary of the 2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement from Shanghai Xuerong Biotechnology Co., Ltd. on the Progress of the 2025 Annual Guarantee Limit Estimate

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Verification Opinion of the Remuneration and Assessment Committee of the Board of Directors of Shanghai XueRong Bio-Technology Co., Ltd. Regarding Matters Related to the Granting of the Company's 2026 Restricted Stock Incentive Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement of Shanghai XueRong Bio-Technology Co., Ltd. Regarding the Granting of Restricted Shares to Incentive Objects of the 2026 Restricted Stock Incentive Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Progress Announcement of Shanghai XueRong Bio-Technology Co., Ltd. Regarding its Wholly-Owned Subsidiary Engaging in Finance Lease Business and the Estimated Guarantee Limit for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement of Resolutions of the Sixth Meeting of the Sixth Board of Directors of Shanghai XueRong Bio-Technology Co., Ltd.

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal Opinion from Guo Hao Law Firm (Shanghai) Regarding Shanghai XueRong Bio-Technology Co., Ltd.'s Granting of Restricted Stock Incentive Plan in 2026

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Progress Announcement of Shanghai XueRong Bio-Technology Co., Ltd. on Estimated Guarantee Quota for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shanghai Snow Dragon Biotech Co., Ltd. Announcement on the Change of Project Partner, Signing Certified Public Accountant, and Quality Control Reviewer for the Audit Firm

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shanghai XueRong Bio-Technology Co., Ltd. Announcement of Resolutions of the Second Extraordinary General Meeting in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shanghai XueRong Bio-Technology Co., Ltd. Self-Inspection Report on Insider Information and Incentive Recipients' Trading of Company Shares under the 2026 Restricted Stock Incentive Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Grandall Law Firm (Shanghai) Legal Opinion on Shanghai XueRong Bio-Technology Co., Ltd.'s Second Extraordinary General Meeting in 2026

Share PledgeShareholding Change DisclosureCapital Reduction

Shanghai Snow Dragon Biotechnology Co., Ltd. Board of Directors Compensation and Assessment Committee's Explanation and Verification Opinion on the Public Disclosure of the List of Incentive Recipients for the 2026 Restricted Stock Incentive Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Articles of Association of Shanghai Xuerong Biotechnology Co., Ltd. (February 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shanghai Xuerong Biotechnology Co., Ltd. Announcement on Completing the Industrial and Commercial Change Registration of the Registered Address

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shanghai Xerong Bio-Technology Co., Ltd. Notice of Convening the Second Extraordinary General Meeting of Shareholders in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shanghai Xerong Bio-Technology Co., Ltd. Announcement of Resolutions of the Fifth Meeting of the Sixth Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal Opinion from Grandall Law Firm (Shanghai) on the First Extraordinary General Meeting of Shareholders of Shanghai Xuerong Biotechnology Co., Ltd. in 2026

Share PledgeShareholding Change DisclosureCapital Reduction

Resolution Announcement of the First Extraordinary General Meeting of Shareholders of Shanghai Xuerong Biotechnology Co., Ltd. in 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shanghai XueRong Biotechnology Co., Ltd. Progress Announcement on the Estimated Guarantee Amount for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notes & Comments

Sign in to leave a comment or private note.

Loading…